US-based medical device company Nervonik has secured $52.5m in Series B financing aimed at advancing its peripheral nerve stimulation (PNS) system. Amzak Health led the funding round, with ...
Medtronic has announced plans to acquire privately held medtech company SPR Therapeutics, a leader in temporary percutaneous peripheral nerve stimulation therapies for chronic pain management.
LOS ANGELES, April 27, 2026 /PRNewswire/ -- Nervonik, Inc., a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies, today announced the ...
Medtronic has entered a deal to acquire SPR Therapeutics, a Cleveland-based company whose flagship product delivers short-term electrical nerve stimulation for chronic pain patients, for approximately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results